Loading clinical trials...
Loading clinical trials...
OBJECTIVES: I. Evaluate the efficacy of intravenous versus oral pulse loading of clomipramine (CMI) followed by a 12-week course of maintenance therapy in patients with obsessive compulsive disorder.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
National Center for Research Resources (NCRR)
Collaborators
NCT06647589 · Obsessive-Compulsive Disorder (OCD)
NCT06804525 · Major Depressive Episode (MDE), Major Depressive Disorder (MDD), and more
NCT04480918 · Treatment Resistant Depression, Major Depressive Episode, and more
NCT05467683 · Obsessive-Compulsive Disorder, Post Traumatic Stress Disorder, and more
NCT03918577 · Obsessive-Compulsive Disorder, Body Dysmorphic Disorders, and more
Stanford University Medical Center
Stanford, California
University of Cincinnati Medical Center
Cincinnati, Ohio
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions